Clinical Trial Update: Examination of Glutamate and mGluR5 in Psychiatric Disorders [NA]

View source ↗

Summary

The Yale University–sponsored trial examining glutamate signaling and mGluR5 involvement in major depressive disorder, post-traumatic stress disorder, and bipol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: Yale University | Conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder | NA | Status: COMPLETED